These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 4080411

  • 1. Ventricular fibrillation in a tetraplegic patient who had a therapeutic level of a tricyclic antidepressant. Case report.
    Levin R, Burtt DM, Levin WA, Ginsberg MB.
    Paraplegia; 1985 Dec; 23(6):354-7. PubMed ID: 4080411
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic monitoring of tricyclic antidepressant drugs].
    Grzesiak M, Beszłej JA, Szewczuk-Bogusławska M.
    Psychiatr Pol; 2003 Dec; 37(5):825-37. PubMed ID: 14631602
    [Abstract] [Full Text] [Related]

  • 3. Tricyclic poisoning--successful management of ventricular fibrillation following massive overdose of imipramine.
    Sandeman DJ, Alahakoon TI, Bentley SC.
    Anaesth Intensive Care; 1997 Oct; 25(5):542-5. PubMed ID: 9352770
    [Abstract] [Full Text] [Related]

  • 4. Hepatic failure associated with imipramine therapy.
    Ilan Y, Samuel D, Reynes M, Tur-Kaspa R.
    Pharmacopsychiatry; 1996 Mar; 29(2):79-80. PubMed ID: 8741026
    [Abstract] [Full Text] [Related]

  • 5. Tricyclic antidepressant-induced seizures and plasma drug concentration.
    Preskorn SH, Fast GA.
    J Clin Psychiatry; 1992 May; 53(5):160-2. PubMed ID: 1592842
    [Abstract] [Full Text] [Related]

  • 6. Possible interaction between imipramine and butalbital.
    Garey KW, Amsden GW, Johns CA.
    Pharmacotherapy; 1997 May; 17(5):1041-2. PubMed ID: 9324197
    [Abstract] [Full Text] [Related]

  • 7. [Arrhythmogenic effects of antidepressive agents demonstrated by programmed ventricular pacing].
    Cointe R, Dussarat GV, Mafart B, Bru P, Levy S.
    Arch Mal Coeur Vaiss; 1989 Mar; 82(3):401-4. PubMed ID: 2502097
    [Abstract] [Full Text] [Related]

  • 8. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC, Tulen JH, van den Broek WW, Bruyn JA, Passchier J, Pepplinkhuizen L.
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [Abstract] [Full Text] [Related]

  • 9. Recurrence of dilated cardiomyopathy after re-introduction of a tricyclic antidepressant.
    Briec F, Delaire C, Bouhour JB, Trochu JN.
    Arch Mal Coeur Vaiss; 2006 Oct; 99(10):933-5. PubMed ID: 17100146
    [Abstract] [Full Text] [Related]

  • 10. Acrocyanosis as a side effect of tricyclic antidepressants: a case report.
    Karakaya I, Aydoğan M, Coşkun A, Gökalp AS.
    Turk J Pediatr; 2003 Oct; 45(2):155-7. PubMed ID: 12921305
    [Abstract] [Full Text] [Related]

  • 11. Brugada syndrome precipitated by a tricyclic antidepressant.
    Chow BJ, Gollob M, Birnie D.
    Heart; 2005 May; 91(5):651. PubMed ID: 15831654
    [No Abstract] [Full Text] [Related]

  • 12. Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications.
    Marshall JB, Forker AD.
    Am Heart J; 1982 Mar; 103(3):401-14. PubMed ID: 7039280
    [No Abstract] [Full Text] [Related]

  • 13. Case report of tricyclic-induced delirium at a therapeutic drug concentration.
    Godwin CD.
    Am J Psychiatry; 1983 Nov; 140(11):1517-8. PubMed ID: 6625006
    [Abstract] [Full Text] [Related]

  • 14. Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring.
    Gründer G, Wetzel H, Schlösser R, Benkert O.
    Pharmacopsychiatry; 1996 Mar; 29(2):72-8. PubMed ID: 8741025
    [Abstract] [Full Text] [Related]

  • 15. Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature -- part II.
    Risch SC, Huey LY, Janowsky DS.
    J Clin Psychiatry; 1979 Feb; 40(2):58-69. PubMed ID: 581671
    [Abstract] [Full Text] [Related]

  • 16. Interstitial lung disease probably caused by imipramine.
    Deshpande PR, Ravi R, Gouda S, Stanley W, Hande MH.
    Am J Ther; 2014 Feb; 21(2):e66-8. PubMed ID: 22960847
    [Abstract] [Full Text] [Related]

  • 17. Euprolactinemic galactorrhea associated with use of imipramine and escitalopram in a postmenopausal woman.
    Mahasuar R, Majhi P, Ravan JR.
    Gen Hosp Psychiatry; 2010 Feb; 32(3):341.e11-3. PubMed ID: 20430243
    [Abstract] [Full Text] [Related]

  • 18. Beta blocker inhibits tricyclic metabolism.
    Gillette DW, Tannery LP.
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):223-4. PubMed ID: 7908665
    [Abstract] [Full Text] [Related]

  • 19. Tricyclic-resistant depression: treatment resistance or inadequate treatment?
    Lydiard RB.
    J Clin Psychiatry; 1985 Oct; 46(10):412-7. PubMed ID: 3900051
    [Abstract] [Full Text] [Related]

  • 20. Plasma monitoring of tricyclic antidepressants: defining the therapeutic range for imipramine in depressed children.
    Preskorn SH, Weller E, Hughes C, Weller R.
    Clin Neuropharmacol; 1986 Oct; 9 Suppl 4():265-7. PubMed ID: 3552217
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.